当前位置: X-MOL 学术Neurotoxicology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adrenergic β receptor activation reduces amyloid β1-42-mediated intracellular Zn2+ toxicity in dentate granule cells followed by rescuing impairment of dentate gyrus LTP.
NeuroToxicology ( IF 3.4 ) Pub Date : 2020-06-05 , DOI: 10.1016/j.neuro.2020.06.001
Haruna Tamano 1 , Yudai Ishikawa 1 , Aoi Shioya 1 , Ryusei Itoh 1 , Naoya Oneta 1 , Ryota Shimaya 1 , Mako Egawa 1 , Paul A Adlard 2 , Ashley I Bush 2 , Atsushi Takeda 1
Affiliation  

Adrenergic β receptor activation prevents human soluble amyloid β (Aβ)-induced impairment of long-term potentiation (LTP) in slices. On the basis of the evidence that human Aβ1–42-induced impairment of LTP is due to Aβ1–42-mediated Zn2+ toxicity, we postulated that adrenergic β receptor activation reduces Aβ1–42-mediated intracellular Zn2+ toxicity followed by rescuing Aβ1–42 toxicity. To test the effect of adrenergic β receptor activation, LTP was recorded at perforant pathway-dentate granule cell synapses of anesthetized rats 60 min after Aβ1–42 injection into the dentate granule cell layer. Human Aβ1–42-induced impairment of LTP was rescued by co-injection of isoproterenol, an adrenergic β receptor agonist, but not by co-injection of phenylephrine, an adrenergic α1 receptor agonist. Isoproterenol did not reduce Aβ1–42 uptake into dentate granule cells, but reduced increase in intracellular Zn2+ in dentate granule cells induced by Aβ1–42. In contrast, phenylephrine did not reduce both Aβ1–42 uptake and increase in intracellular Zn2+ by Aβ1–42. In the case of human Aβ1−40 and rat Aβ1–42, which do not increase intracellular Zn2+, human Aβ1−40- and rat Aβ1–42-induced impairments of LTP were not rescued by co-injection of isoproterenol. The present study indicates that adrenergic β receptor activation reduces Aβ1–42-mediated increase in intracellular Zn2+ in dentate granule cells, resulting in rescuing Aβ1–42-induced impairment of LTP. It is likely that noradrenergic neuron activation by stimulating the locus coeruleus is effective for rescuing Aβ1–42-induced cognitive decline that is caused by intracellular Zn2+ dysregulation in the hippocampus.



中文翻译:

肾上腺素β受体的激活减少了齿状颗粒细胞中淀粉样蛋白β1-42介导的细胞内Zn2 +毒性,随后挽救了齿状回LTP的损伤。

肾上腺素β受体激活可防止人类可溶性淀粉样β(Aβ)引起的片中长期增强(LTP)损伤。根据证据表明人类Aβ1–42诱导的LTP损伤是由于Aβ1–42介导的Zn 2+毒性所致,我们推测肾上腺素β受体激活会降低Aβ1–42介导的细胞内Zn 2+毒性然后抢救Aβ1–42毒性。为了测试肾上腺素β受体激活的作用,在将Aβ1–42注入齿状颗粒细胞层后60分钟,在麻醉大鼠的穿孔途径-齿状颗粒细胞突触中记录LTP 。人Aβ1–42LTP的诱导损伤是由异丙肾上腺素的共注射,肾上腺素能β受体激动剂,但不是由去氧肾上腺素的共注射,肾上腺素能α救出1受体激动剂。异丙肾上腺素不会减少齿状颗粒细胞对Aβ1–42的摄取,但会减少由Aβ1–42诱导的齿状颗粒细胞中细胞内Zn 2+的增加。相比之下,去氧肾上腺素并没有减少Aβ两者1-42摄取和增加细胞内锌2+由Aβ 1-42。对于不增加细胞内Zn 2+的人Aβ1−40和大鼠Aβ1–42,人Aβ1−40-和大鼠Aβ共注射异丙肾上腺素不能挽救1–42引起的LTP损伤。本研究表明,肾上腺素能β受体的活化减少了齿状颗粒细胞中Aβ1–42介导的细胞内Zn 2+的增加,从而挽救了Aβ1–42诱导的LTP损伤。通过刺激蓝斑轨迹来激活去甲肾上腺素能神经元对于挽救Aβ1–42引起的认知衰退是有效的,这是由海马中细胞内Zn 2+失调引起的。

更新日期:2020-06-05
down
wechat
bug